Three-year real-world effectiveness of dupilumab in eosinophilic CRSwNP across upper and lower airways

Daiki Nakashima, Masahiro Yoshida, Shunsuke Minagawa, Takanori Numata, Tetsuya Adachi, Tsuguhisa Nakayama, Yoshinori Matsuwaki

Open source

DOI
10.1016/j.alit.2026.09.011
Published
2026-10
Container
Allergology International
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.alit.2026.09.011,
  title = {Three-year real-world effectiveness of dupilumab in eosinophilic CRSwNP across upper and lower airways},
  author = {Daiki Nakashima and Masahiro Yoshida and Shunsuke Minagawa and Takanori Numata and Tetsuya Adachi and Tsuguhisa Nakayama and Yoshinori Matsuwaki},
  year = {2026},
  journal = {Allergology International},
  doi = {10.1016/j.alit.2026.09.011},
  url = {https://doi.org/10.1016/j.alit.2026.09.011}
}

RIS

TY  - JOUR
TI  - Three-year real-world effectiveness of dupilumab in eosinophilic CRSwNP across upper and lower airways
AU  - Daiki Nakashima
AU  - Masahiro Yoshida
AU  - Shunsuke Minagawa
AU  - Takanori Numata
AU  - Tetsuya Adachi
AU  - Tsuguhisa Nakayama
AU  - Yoshinori Matsuwaki
PY  - 2026
JO  - Allergology International
DO  - 10.1016/j.alit.2026.09.011
UR  - https://doi.org/10.1016/j.alit.2026.09.011
ER  - 

APA

Nakashima, D., Yoshida, M., Minagawa, S., Numata, T., Adachi, T., Nakayama, T., & Matsuwaki, Y. (2026). Three-year real-world effectiveness of dupilumab in eosinophilic CRSwNP across upper and lower airways. Allergology International. https://doi.org/10.1016/j.alit.2026.09.011

Source records